Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 11, 2016 5:59 AM ET

Pharmaceuticals

Company Overview of Novartis Institutes for BioMedical Research, Inc.

Company Overview

Novartis Institutes for BioMedical Research, Inc. operates as a pharmaceutical research organization. The company was incorporated in 2002 and is based in Cambridge, Massachusetts. Novartis Institutes for BioMedical Research, Inc. operates as a subsidiary of Novartis AG.

250 Massachusetts Avenue

Cambridge, MA 02139

United States

Founded in 2002

Phone:

617-871-8000

Fax:

617-551-9540

Key Executives for Novartis Institutes for BioMedical Research, Inc.

President
Age: 64
Head of Public Relations
Deputy Chief Financial Officer and Chief Financial Officer of Novartis AG
Age: 56
Chief Operating Officer
Age: 59
Chief Executive Officer of Novartis Animal Health
Age: 64
Compensation as of Fiscal Year 2015.

Novartis Institutes for BioMedical Research, Inc. Key Developments

Novartis Institutes for BioMedical Research, Inc. Presents at BIO-Europe 2015, Nov-02-2015

Novartis Institutes for BioMedical Research, Inc. Presents at BIO-Europe 2015, Nov-02-2015 . Venue: Munich, Germany.

Novartis AG Announces Executive Changes at Novartis Institutes for BioMedical Research, Inc., Effective March 1, 2016

Novartis AG announced that Dr. James (Jay) E. Bradner has been appointed President of the Novartis Institutes for BioMedical Research (NIBR) and a member of the Executive Committee of Novartis, effective March 1, 2016. Dr. Bradner succeeds Mark C. Fishman, M.D., who will reach his contractual retirement age in March 2016 after a distinguished 13-year career at Novartis as the leader of the company's drug discovery and early clinical development efforts.

Novartis Institutes for BioMedical Research Announces Executive Changes

Novartis announced that Dr. James (Jay) E. Bradner, physician-scientist from Dana-Farber Cancer Institute and Harvard Medical School, has been appointed President of the Novartis Institutes for BioMedical Research (NIBR), effective March 1, 2016. Dr. Bradner succeeds Mark C. Fishman, M.D., who will reach his contractual retirement age in March 2016. Dr. Bradner will be based at NIBR's global headquarters in Cambridge, Massachusetts and report to Joseph Jimenez, Chief Executive Officer of Novartis. He will join Novartis on January 1, 2016 to work alongside Dr. Fishman and the NIBR leadership team to ensure a smooth transition. Dr. Bradner is on the faculty of Harvard Medical School in the Department of Medical Oncology at the Dana-Farber Cancer Institute. Dr. Bradner has co-authored more than 130 scientific publications and 30 United States Patent applications.

Similar Private Companies By Industry

Company Name Region
AstaHealth United States
Continuus Pharmaceuticals, Inc. United States
Three Rivers Pharmaceuticals, LLC United States
Tetra Discovery Partners LLC United States
Hera Biomedical, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
April 15, 2015
Aduro BioTech, Inc.
Merger/Acquisition
March 5, 2015
Novartis Institutes for BioMedical Research, Inc., RNAi Assets
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Novartis Institutes for BioMedical Research, Inc., please visit www.nibr.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.